Reappraising prognostic factors after SRS/FSRT of brain metastases in the era of targeted therapies

被引：0
|
作者：
Fink, Christoph A. [1 ]
Tawk, Bouchra [1 ]
Hahnemann, Laura [1 ]
Christopoulos, Petros [2 ]
Hoerner-Rieber, Juliane [1 ]
Weykamp, Fabian [1 ]
Lang, Kristin [1 ]
Thomas, Michael [2 ]
Debus, Juergen [1 ]
Koenig, Laila [1 ]
机构：
[1] Univ Hosp Heidelberg, Radiat Oncol, Heidelberg, Germany
[2] Dept Thorac Oncol, Thoraxklin, Heidelberg, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2024年 / 194卷
关键词：
targeted therapy; checkpoint inhibition; SRS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页码：S816 / S819
页数：5
相关论文
共 50 条
  • [1] Prognostic Factors in the Era of Targeted Therapies in CLL
    Prajwal Boddu
    Alessandra Ferrajoli
    Current Hematologic Malignancy Reports, 2018, 13 : 78 - 90
  • [2] Prognostic Factors in the Era of Targeted Therapies in CLL
    Boddu, Prajwal
    Ferrajoli, Alessandra
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2018, 13 (02) : 78 - 90
  • [3] SRS alone of brain metastases with unfavorable prognostic factors
    Harat, M.
    Blok, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S464 - S465
  • [4] Prognostic factors of brain metastases from breast cancer: Impact of targeted therapies
    Braccini, Antoine Laurent
    Azria, David
    Thezenas, Simon
    Romieu, Gilles
    Ferrero, Jean Marc
    Jacot, William
    BREAST, 2013, 22 (05): : 993 - 998
  • [5] Management of Brain Metastases in the Era of Targeted and Immunomodulatory Therapies
    Brastianos, Priscilla K.
    Cahill, Daniel P.
    ONCOLOGY-NEW YORK, 2015, 29 (04): : 261 - 263
  • [6] Radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT) in the treatment of brain metastases
    Beltramo, G.
    Mantovani, C.
    Zeme, S.
    Soffietti, R.
    Ricardi, U.
    ANNALS OF ONCOLOGY, 2006, 17 : XI61 - XI62
  • [7] Relevance of Prognostic Factors in the Era of Targeted Therapies in CLL
    Kittai, Adam S.
    Lunning, Matthew
    Danilov, Alexey V.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2019, 14 (04) : 302 - 309
  • [8] Relevance of Prognostic Factors in the Era of Targeted Therapies in CLL
    Adam S. Kittai
    Matthew Lunning
    Alexey V. Danilov
    Current Hematologic Malignancy Reports, 2019, 14 : 302 - 309
  • [9] Factors Associated with Hemorrhage of Melanoma Brain Metastases after Stereotactic Radiosurgery in the Era of Targeted/Immune Checkpoint Inhibitor Therapies
    Zoga, Eleni
    Wolff, Robert
    Ackermann, Hanns
    Meissner, Markus
    Rodel, Claus
    Tselis, Nikolaos
    Chatzikonstantinou, Georgios
    CANCERS, 2022, 14 (10)
  • [10] Outcomes of fSRT compared to SRS for brain metastases by using volumetric surrogates for fractionation
    Abacioglu, M. U.
    Ozen, Z.
    Arifoglu, A.
    Ibrahimov, R.
    Gunhan, B.
    Kayalilar, N.
    Gurdalli, S.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S402 - S402
12345